John Leite - 06 Mar 2025 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Signature
/s/ Jonathan Wygant as attorney-in-fact
Issuer symbol
VCYT
Transactions as of
06 Mar 2025
Net transactions value
-$234,630
Form type
4
Filing time
10 Mar 2025, 16:43:53 UTC
Previous filing
03 Mar 2025
Next filing
04 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCYT Common Stock Award $0 +36,240 +51% $0.000000 107,660 06 Mar 2025 Direct F1
transaction VCYT Common Stock Sale $74,484 -2,400 -2.2% $31.04 105,260 07 Mar 2025 Direct F2, F3
transaction VCYT Common Stock Sale $160,146 -5,011 -4.8% $31.96 100,249 07 Mar 2025 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Restricted stock units awarded on March 6, 2025 vest 25% on March 2, 2026 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.
F2 The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 6, 2024.
F3 Represents weighted average sales price. Sale prices for the transactions range from $30.63 to $31.61. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F4 Represents weighted average sales price. Sale prices for the transactions range from $31.71 to $32.44. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.